NCT04676438 is a clinical trial in Breast Neoplasms, sponsored by Moroccan Society of Surgery.

Who is sponsoring NCT04676438?

NCT04676438 is sponsored by Moroccan Society of Surgery.

What condition does NCT04676438 study?

NCT04676438 studies Breast Neoplasms, Pain, Postoperative, Pain, Chronic.

Is NCT04676438 still recruiting?

NCT04676438 is currently completed. Last updated 20 July 2021.

Last reviewed 2021-07-20 · How we verify

NCT04676438

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors

Completed Last updated 20 July 2021

What this trial tests

trial in Breast Neoplasms in 722 participants. Completed in 7 March 2021.

Timeline

10 December 2018

Primary endpoint
8 September 2020

7 March 2021

Quick facts

Lead sponsor	Moroccan Society of Surgery
Status	Completed
Study type	OBSERVATIONAL
Enrollment	722
Start date	10 December 2018
Primary completion	8 September 2020
Estimated completion	7 March 2021
Sites	2 locations across Morocco

Conditions studied

Breast Neoplasms — all drugs for Breast Neoplasms →
Pain, Postoperative — all drugs for Pain, Postoperative →
Pain, Chronic — all drugs for Pain, Chronic →

Sponsor

Moroccan Society of Surgery

Who can join

18 and older, female only, with Breast Neoplasms or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post Mastectomy Pain Syndrome (PMPS) is a major complication of breast surgery responsible for depression and disability. The project consists of a prospective cohort on patients going for oncological breast surgery at National Institute of Oncology of Rabat. Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem, which could last for more than 3 months after surgery. The aim of present study was to assess the prevalence of CPP, investigate its impact on life quality and explore its potential risk factors. After informed consent was signed, patients receiving surgery under general anesthesia in Peking Union Medical College Hospital and other medical centers participating in this study during 2018 will be included. Patients' preoperative information will be collected from medical record, including basic demographic data, primary disease and previous chronic diseases. Intraoperative information will be obtained from anesthesia record, including surgical scope, duration, length and location of incisions and blood loss. Acute pain will be evaluated in the ward of the department of surgery, when an app will be installed on patients' mobile phones. Our long-term postoperative follow-up would be performed by sending out survey questionnaires via this app in the 4th, 8th, 16th, 32th, and 48th weeks after surgery. The survey covers questions regarding the intensity, characteristic, location and impact on daily activities of CPP. Information regarding treatment of CPP will also be collected, if any. All the data gained will be summarized in our database and analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Neoplasms

Currently open trials in the same condition.

NCT07214532 — Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · NA · recruiting
NCT07500428 — Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models · recruiting
NCT07581834 — Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multic · Phase 2 · recruiting
NCT07222215 — PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) · Phase 2 · recruiting
NCT07465393 — Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors · NA · recruiting

Other Moroccan Society of Surgery trials

Trials by the same sponsor.

NCT04607577 — Cross-cultural Adaptation and Validation in Moroccan Arabic Dialect "Darija" of the QoR-15 Postoperative Recovery Qualit · unknown
NCT05494281 — Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer · NA · unknown
NCT04130568 — Translation and Adaptation of Learning Organisation Survey for French Speaking Countries · completed
NCT04000802 — Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers · completed
NCT05286411 — Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04676438 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moroccan Society of Surgery
Last refreshed: 20 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04676438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing